Médecine

Paramédical

Autres domaines


S'abonner

The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic - 19/08/11

Doi : 10.1016/j.jaad.2007.02.036 
Jessica Risser, MD, MPH a, Zakiya Pressley, MD a, Emir Veledar, PhD b, Carl Washington, MD a, Suephy C. Chen, MD, MS a, c,
a From the Department of Dermatology 
b Center for Outcomes Research, Emory University 
c Department of Health Services Research and Development, Atlanta Department of Veterans Affairs Medical Center 

Reprint requests: Suephy C. Chen, MD, MS, Department of Dermatology, Emory University, 101 Woodruff Circle, Atlanta, GA 30322.

Atlanta, Georgia

Abstract

Background

Total body cutaneous photography is increasingly being used by dermatologists to monitor patients at risk for the development of melanoma, but limited evidence exists regarding the impact of such photography on melanoma and melanoma-related outcomes.

Objective

We sought to compare biopsy number in patients with multiple atypical nevi in their first year of care at our pigmented lesion clinic (PLC) between those who received total body skin examination alone and those who received total body skin examination and total body digital photography (TBDP). We sought to identify predictors of biopsy number and number of dysplastic nevi diagnosed in patients with multiple atypical nevi.

Methods

A chart review was performed of patients attending the PLC during the years 1998 to 2003 to identify the number of biopsies performed in the first year of care. Patient demographics, melanoma risk factors, and melanoma outcome events were also abstracted from the charts.

Results

The mean number of biopsies performed in patients in their first year of care at the PLC in those who did not receive TBDP was equal to the mean number of biopsies performed in patients who did receive TBDP (0.82 and 0.8, respectively). Linear regression analysis revealed that the interaction term between a lack of both personal history of melanoma and severe dysplastic nevi (−0.930, P = .005) has a significant protective effect on the number of biopsies. Similar regression analysis also showed that the interaction term between a lack of both personal history of melanoma and of severe dysplastic nevi (−1.209, P < .0001), increasing provider experience (−0.047, P = .029), and increased number of biopsies before the initial PLC (−0.028, P = .050) have a statistically significant protective effect on the number of dysplastic nevi diagnosed in the first year of PLC. TBDP did not have an effect on the number of biopsies or on the number of dysplastic nevi diagnosed in the first year of care at the PLC.

Limitations

This study is limited by being retrospective in nature, having a small sample size, and having a short follow-up period.

Conclusion

Overall, this small retrospective study does not provide evidence that would suggest that TBDP changes provider behavior in caring for patients at high risk for melanoma. Rather, our study supports the fact that a patient’s positive history of melanoma and a history of severe dysplastic nevi have the most significant impact on provider biopsy behavior, resulting in a lower threshold to biopsy suggestive lesions.

Le texte complet de cet article est disponible en PDF.

Plan


 Drs Chen and Veledar are supported in part by a Mentored Patient Oriented Career Development Award (No. K23AR02185-01A1).
Conflicts of interest: None declared.
An abstract of this work was presented at the American Academy of Dermatology Annual Meeting, San Francisco, Calif, on March 4, 2006 and published in the poster abstract edition.


© 2007  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 57 - N° 3

P. 428-434 - septembre 2007 Retour au numéro
Article précédent Article précédent
  • Chronic atrophic erosive dermatosis of the scalp and extremities: A recharacterization of erosive pustular dermatosis
  • Douglas Patton, Peter J. Lynch, Maxwell A. Fung, Nasim Fazel
| Article suivant Article suivant
  • Change of address

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.